Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 16/20 | 0.58 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31508535 | 1.00 | STS (0.58) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL12269980 | 0.92 | STS (0.59) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL6692712 | 0.92 | STS (0.60) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL31508300 | 0.87 | STS (0.53) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL12269944 | 0.87 | STS (0.53) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL12269922 | 0.86 | STS (0.62) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL1657345 | 0.81 | ESR1 (0.53) | STSESR1LMNACYP1A2CYP3A4 | |
| SCHEMBL13021545 | 0.81 | STS (0.57) | STS | |
| SCHEMBL13021551 | 0.81 | STS (0.57) | STS | |
| SCHEMBL13336961 | 0.79 | LMNA (0.50) | STSESR1LMNACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097061-A1 | ApoB DEGRADING COMPOUNDS AND USES THEREOF | AVILAR THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |